Claudia Loureiro-Chaves

Coimbra, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Recommendations for quality care indicators in severe asthma multidisciplinary units in Portugal (PRECISION project): A nationwide consensus.

Recommendations for quality care indicators in severe asthma multidisciplinary units in Portugal (PRECISION project): A nationwide consensus.

Journal: Pulmonology

Published: July 31, 2026

Benralizumab effectiveness in a real-world Portuguese severe eosinophilic asthma population: BETREAT study.

Benralizumab effectiveness in a real-world Portuguese severe eosinophilic asthma population: BETREAT study.

Journal: Pulmonology

Published: July 17, 2026

Managing multimorbidity in severe asthma: comparison of resources and perspectives between severe asthma specialists and general respiratory physicians across Europe.

Managing multimorbidity in severe asthma: comparison of resources and perspectives between severe asthma specialists and general respiratory physicians across Europe.

Journal: ERJ open research

Published: February 17, 2026

Daily digital biomarkers in the follow-up and clustering of patients with asthma.

Daily digital biomarkers in the follow-up and clustering of patients with asthma.

Journal: Pulmonology

Published: July 28, 2025

Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics.

Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics.

Journal: American journal of respiratory and critical care medicine

Published: May 18, 2025

Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT).

Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT).

Journal: Expert review of clinical immunology

Published: January 03, 2025

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).

Journal: The World Allergy Organization journal

Published: December 18, 2024

The impact of patient and public involvement in chronic respiratory disease research: the ConectAR experience.

The impact of patient and public involvement in chronic respiratory disease research: the ConectAR experience.

Journal: Breathe (Sheffield, England)

Published: October 09, 2023

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.

Journal: The European respiratory journal

Published: September 08, 2023

Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.

Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.

Journal: Pulmonology

Published: August 05, 2023

Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.

Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.

Journal: Allergy

Published: February 23, 2023

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.

Journal: Allergy

Published: October 12, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026